Mylan to sell up to $363 million stake in India's Biocon, term sheet shows
- Posted on July 13, 2026
- By Business News Today
- 0 Views
- 1 min read
In brief
Mylan Inc is divesting a significant portion of its stake in Biocon Ltd, India's leading biopharmaceutical company, through the sale of approximately 92 million shares valued at roughly $363 million. This strategic divestment reflects Mylan's portfolio optimization efforts and demonstrates continued investor confidence in Biocon's growth trajectory within the Indian pharmaceutical sector. The transaction underscores the expanding role of Indian biotech firms in global healthcare markets.
Summary auto-generated by AI from the original publisher's content. Editorial standards.
Mylan to sell up to $363 million stake in India's Biocon, term sheet shows
Mylan Inc plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd, worth up to 34.81 billion Indian rupees ($363 million), according to a term sheet seen by Reuters.
